Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Saved in:
| Title: | Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. |
|---|---|
| Authors: | Alban TJ; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States., Bayik D; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States., Otvos B; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States.; Cleveland Clinic, Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, United States., Rabljenovic A; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States., Leng L; Departments of Medicine, Pathology, and Epidemiology & Public Health, Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States., Jia-Shiun L; Department of Neurology, Houston Methodist Research Institute, Houston, TX, United States., Roversi G; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States., Lauko A; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States., Momin AA; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States., Mohammadi AM; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, United States., Peereboom DM; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, United States., Ahluwalia MS; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, United States., Matsuda K; Medicinova Inc., La Jolla, CA, United States., Yun K; Department of Neurology, Houston Methodist Research Institute, Houston, TX, United States.; Department of Neurosurgery, Weill Cornell Medical College, New York, NY, United States., Bucala R; Departments of Medicine, Pathology, and Epidemiology & Public Health, Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States., Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, United States., Lathia JD; Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2020 Jun 18; Vol. 11, pp. 1191. Date of Electronic Publication: 2020 Jun 18 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2020.01191 |
